2022--provirex--hamburg-researchers-want-to-be-able-to-cure-hiv-soon---magazine--healty-and-sport-news ✧

In October 2022, PROVIREX announced a major expansion in Hamburg’s .

Building upon the research conducted by and the University Medical Center Hamburg-Eppendorf (UKE) , this paper outlines the scientific and strategic progress made toward a functional HIV cure as of late 2022. Abstract In October 2022, PROVIREX announced a major expansion

Preclinical data showed the enzyme has no measurable cytotoxic or genotoxic side effects, making it a viable candidate for human testing. 3. 2022 Milestones: The Hamburg Therapy Hub In October 2022

The core of Hamburg’s research is , developed through directed molecular evolution by teams led by Prof. Joachim Hauber. In October 2022, PROVIREX announced a major expansion